Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (4787 companies, A–Z).
GeoVax Labs said on November 5, 2026 that its Board terminated David A. Dodd as President and Chief Executive Officer, effective immediately, and treated the termination as for Cause under his 2018 Employment Agreement. Dodd remains a director and Chairman, and the company does not intend to pay the severance he would receive without Cause, but he may dispute the determination, which could lead to severance and option-vesting costs.
Termination of President and CEO David A. Dodd effective immediately, dated November 5, 2026; he remains a director and Chairman
Board cites Dodd's refusal to comply with Board-approved directives as the basis for Cause
Company does not intend to pay severance, including a cash payment of three times base salary and target bonus, or full option vesting; Dodd may dispute and claim these
Company states the termination is unrelated to its business operations, financial results, or previously filed financial statements
Change Agents Corporation appointed Chief Strategy Officer Luisa Ingargiola as principal executive officer on November 4, 2026, until it names a new Chief Executive Officer, with no added compensation. The company also issued a $250,000 promissory note to Harllon Holdings LLC with a $75,000 original issue discount, requiring repayment of $325,000 on January 1, 2027, and agreed to issue 150,000 shares to consultants for services.
Luisa Ingargiola, Chief Strategy Officer since June 3, 2026, was appointed principal executive officer on November 4, 2026, and will receive no additional compensation for the role.
Promissory note issued November 4, 2026 to Harllon Holdings LLC: $250,000 principal, $75,000 original issue discount, $325,000 due January 1, 2027.
The note may be prepaid on December 1, 2026 for $312,000.
150,000 shares of common stock agreed to be issued to consultants for services, under the Section 4(a)(2) registration exemption.
Valion Bio, Inc. disclosed that Lisa Wolf, its President, Chief Operating Officer and Chief Financial Officer, has voluntarily resigned from all three roles, with the resignation effective December 11, 2026. The filing does not state a reason or name a successor, so shareholders will need to watch for a replacement announcement.
Lisa Wolf notified the Special Committee of the Board on October 31, 2026.
Her resignation covers the positions of President, Chief Operating Officer and Chief Financial Officer.
The resignation takes effect December 11, 2026, and had not yet taken effect as of the filing date.
At its October 28, 2026 annual meeting, five director nominees did not receive a majority of votes cast and offered conditional resignations, which the board will accept or reject and announce within 90 days after certification. Shareholders also voted 956,752 against versus 422,593 for the say-on-pay proposal, and Executive Vice President Jamie Suarez is leaving his officer role after October 30, 2026, with employment ending November 22, 2026.
Five nominees did not win a majority: Andrew Alfano, Lockie Andrews, Nancy Benacci, Susan Lintonsmith and Michael Mansbach.
Say-on-pay vote: 956,752 against, 422,593 for and 76,907 abstain, with 592,063 broker non-votes.
The board will publicly announce its decision on the offered resignations within 90 days after the election results are certified.
Jamie Suarez's officer role ends at the end of October 30, 2026; his employment ends November 22, 2026, with severance subject to a release of claims.
Three Anavex directors, including Chair Jiong Ma, resigned effective October 28, 2026, each citing views on strategy not aligned with the Board and management. The Board then reconstituted its audit, compensation and nominating committees on November 1, 2026, with new chairs and members.
Jiong Ma (Chair), Gautam Patel and Adrian Senderowicz resigned from the Board effective October 28, 2026
Ma and Patel cited strategic views not aligned with the Board and management; Patel and Senderowicz cited strategy to execute the business plan
Dr. Claus van der Velden chairs the Audit Committee; Dr. Peter Donhauser chairs the Compensation Committee; Dr. Axel Paeger chairs Nominating & Corporate Governance
Resignation letters are filed as Exhibits 17.1, 17.2 and 17.3
Cyngn Inc. told Nasdaq that its audit committee will fall to two members when director Karen Macleod's resignation takes effect, below Nasdaq's three-member requirement. The company expects until the earlier of its next annual meeting or November 3, 2027 to regain compliance by appointing a qualified independent director.
Macleod, Audit Committee Chair, will not stand for re-election at the November 3, 2026 Annual Meeting and resigns when the polls close
Nasdaq Listing Rule 5605(c)(2)(A) requires at least three audit committee members, including one financially sophisticated member
Cyngn expects a compliance deadline of the earlier of its next annual meeting or November 3, 2027
Macleod said her decision was not the result of any disagreement with the company
PennyMac Financial reported third-quarter 2026 net income of $29 million, or $0.54 per diluted share, down from $182 million a year earlier, while total net revenues fell 26% to $469 million. The company also named Kevin Ryan as its next Chief Financial Officer effective January 1, 2027, succeeding Daniel Perotti, and amended employment agreements with Chairman and CEO David Spector and President Doug Jones. Management said fourth-quarter adjusted return on equity is expected to remain near current levels.
Q3 2026 net income was $29 million, or $0.54 diluted EPS, versus $182 million, or $3.37, in Q3 2025; total net revenues were $469 million, down 26% year over year.
Adjusted diluted EPS was $1.05, down from $1.39 in Q2 2026; production segment posted a $7 million pretax loss.
Kevin Ryan, currently Chief Strategy Officer, becomes CFO on January 1, 2027; Daniel Perotti resigns as CFO effective December 31, 2026 and moves to an advisory role.
Doug Jones, President and Chief Mortgage Banking Officer, is set to retire June 30, 2027; Spector's term runs through December 31, 2031.
CooperCompanies said Albert G. White III stepped down as President, Chief Executive Officer and director on October 27, 2026, and independent director Walter M. Rosebrough, Jr. was named interim Executive Chair. The press release said the company's recent performance has not met expectations, and the company reaffirmed its fiscal 2026 guidance. Shareholders face a leadership change while a permanent CEO is sought, and the board is changing composition with Shlomo Nachman joining in December 2026 and three directors not seeking reelection.
Albert G. White III resigned as President, CEO and director effective October 27, 2026, and will remain a strategic advisor through April 1, 2027.
Walter M. Rosebrough, Jr. was appointed interim Executive Chair effective immediately; a CEO Search Committee of Lawrence E. Kurzius, Cynthia L. Lucchese and Teresa S. Madden will oversee the CEO search.
Shlomo Nachman will join the board effective December 8, 2026; Barbara Carbone, Colleen E. Jay and Robert S. Weiss will not stand for reelection at the 2027 Annual Meeting.
The company reaffirmed its fiscal 2026 guidance provided on September 9, 2026.
LiveWire Group's chief executive, Karim Donnez, resigned effective October 21, 2026. The board added two directors and formed a Special Restructuring Committee with authority over any financing, sale, restructuring or other strategic transaction, and that committee appointed Roy Gallagher of Ankura Consulting as Chief Restructuring Officer, reporting as the principal executive officer. The filing points to a possible restructuring, though it does not state the company's financial condition or any specific transaction, and it does not report quarterly results.
Karim Donnez resigned as CEO effective October 21, 2026
Roy Gallagher appointed Chief Restructuring Officer effective October 25, 2026; Company pays Ankura a monthly fee of $140,000 for his services
Special Restructuring Committee formed October 22, 2026 with authority over financing, sale, restructuring and other strategic transactions
Third quarter financial results to be released before market hours on October 29, 2026
Game Your Game amended two warrants held by Streeterville Capital, LLC, covering 250,000 and 1,250,000 shares, to reduce the exercise price to $1.00 per share, and Streeterville waived certain trigger provisions in related agreements. The company also appointed Wendy Loundermon as Chief Financial Officer effective October 16, 2026, and raised CEO Soumya Das's base salary and maximum annual bonus. Lower warrant pricing and higher executive pay can affect shareholder value, so both changes merit attention from investors.
Warrants for 250,000 shares (dated March 31, 2026) and 1,250,000 shares (dated June 30, 2026), both issued to Streeterville Capital, LLC, now have a $1.00 exercise price effective as of the Disclosure Date.
Wendy Loundermon was appointed CFO effective October 16, 2026, succeeding Dominic Poole, who remains Vice President of Finance with no compensation change.
Loundermon's agreement provides a $200,000 base salary, a $25,000 signing bonus and stock options on 200,000 shares vesting over 48 months.
CEO Soumya Das's base salary rose from $200,000 to $300,000 effective October 1, 2026, and his maximum annual bonus rose from $50,000 to $200,000.
LKQ preliminarily reported third-quarter 2026 revenue of $3.32 billion, down from $3.50 billion a year earlier, and a net loss of $16 million to $32 million, compared with net income of $178 million in the third quarter of 2025. The company cited underperformance in Europe, withdrew its full-year 2026 guidance, and replaced CEO Justin Jude with Salvatore A. Abbate, effective December 15, 2026, with an interim Office of the CEO in place until then.
Preliminary Q3 2026 revenue was $3.32 billion versus $3.50 billion in Q3 2025; parts and services organic revenue declined 5.4%.
Diluted loss per share of $0.06 to $0.12 compares with diluted EPS of $0.69 a year earlier; adjusted diluted EPS was $0.47 to $0.53 versus $0.84.
Europe parts and services organic revenue declined 9.8%, and Europe segment EBITDA margin was 4.1% to 5.1%, versus 10.0% a year earlier.
Full-year 2026 guidance, last updated July 30, 2026, is withdrawn; Andy Hamilton left LKQ Europe and Alvarez & Marsal was retained to advise on European operations.
Shuttle Pharmaceuticals Holdings dismissed Forvis Mazars, LLP as its independent registered public accounting firm, effective after the filing of its Form 10-Q for the quarter ended September 30, 2026. The filing says the company has not yet engaged a replacement, and it cites multiple previously disclosed material weaknesses in internal control over financial reporting, which the company says were discussed with Forvis Mazars.
Audit Committee and full Board approved the dismissal of Forvis Mazars on October 16, 2026.
Forvis Mazars's reports for fiscal 2025 and 2024 included an explanatory paragraph on substantial doubt about the company's ability to continue as a going concern.
The company reports four material weaknesses, including limited accounting policies, insufficient review and segregation of duties, and information technology general control findings.
No successor auditor had been engaged as of the filing date; Forvis Mazars's letter is dated October 21, 2026 and filed as Exhibit 16.1.
Terra Innovatum Global N.V. dismissed KPMG Accountants N.V. as its independent auditor, effective October 12, 2026, and intends to engage MaloneBailey, LLP for fiscal 2026. The company says the change was not due to any disagreement with KPMG, but the filing notes material weaknesses in internal control over financial reporting that have not been remediated.
Audit Committee dismissed KPMG on October 9, 2026, effective October 12, 2026.
KPMG's report on fiscal 2025 financial statements contained no adverse opinion, disclaimer, or qualification.
Filing cites material weaknesses in internal control disclosed in the 2025 Form 10-K and the June 30, 2026 Form 10-Q, which have not been remediated.
MaloneBailey previously audited the company from April 29, 2025 to January 15, 2026; engagement is subject to client acceptance procedures.
Verra Mobility said Chief Financial Officer Craig Conti will resign effective November 4, 2026, to pursue an opportunity in a different industry, and that the departure is not related to financial or operating results. The company is searching for a permanent CFO and expects to name an interim CFO, and it reaffirmed its 2026 full-year outlook, which it first presented on August 5, 2026.
Conti notified the company on October 8, 2026, and his last day is November 4, 2026
The board has begun a search for a permanent CFO with Spencer Stuart and expects to appoint an interim CFO
Third quarter 2026 results will be released before market open on October 30, 2026, with no conference call planned
The company reaffirmed its 2026 full-year outlook, originally presented on August 5, 2026
Sidus Space disclosed that two board members resigned effective October 6, 2026: Tiffany Norwood, who also chaired the Audit Committee, and Kelle Wendling. Both cited governance and oversight concerns, and the company disagrees with their stated reasons. The departures remove the audit committee chair and raise questions about board oversight for shareholders.
Tiffany Norwood resigned from the Board, as Audit Committee Chairwoman, and from the Corporate Governance/Nominating Committee, effective October 6, 2026 at 7:15 p.m. ET, citing disagreements over governance and oversight, including handlin
Kelle Wendling resigned from the Board and from the Audit, Compensation and Corporate Governance/Nominating Committees, effective October 6, 2026 at 1:00 p.m. ET, citing concerns about management and governance.
The company said it respectfully disagrees with the substance and characterizations in both resignation letters; both letters are filed as Exhibits 17.1 and 17.2.
Lifeward Ltd. said on October 4, 2026 that Rami Aviram, whom it had appointed as Chief Financial Officer effective November 1, 2026, has decided not to join and will not take the role. Josh Hexter will continue as interim principal financial officer and principal accounting officer until a successor is appointed, and the company is searching for a permanent CFO. The change leaves the finance leadership role unfilled and without a set date for a successor.
Rami Aviram informed the company on October 4, 2026 that he will not join as CFO, which was originally set for November 1, 2026.
Josh Hexter remains interim principal financial officer and principal accounting officer, with no additional compensation for these duties.
The company is conducting a search for a permanent CFO and will announce a successor when the search concludes.
On October 1, 2026, holders of a majority of Hub Group's voting power, including Yeager family trusts, acted by written consent to remove three directors, appoint four new directors, and adopt Second Amended and Restated Bylaws. Three other directors resigned the same day, and the company says David P. Yeager remains Chairman and CEO. The changes come while Hub Group works to complete a restatement and file delayed periodic reports and faces a Nasdaq delisting process with a hearing set for October 27, 2026.
Michael Flannery, Peter McNitt, and Gary Yablon were removed as directors without cause, effective October 1, 2026.
Gregory D. Bunch, Thomas P. Fitzgerald, Thaddeus J. Malik, and Thomas M. White were appointed as directors, effective October 1, 2026.
Mary H. Boosalis, Jenell Ross, and Martin P. Slark resigned from the Board, effective October 1, 2026.
Nasdaq issued a Staff Delisting Determination on September 16, 2026; the company has appealed, and the Nasdaq Hearings Panel hearing is scheduled for October 27, 2026, with the delisting stayed pending the outcome.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.